[go: up one dir, main page]

GB202204884D0 - Sirna targeting kcna1 - Google Patents

Sirna targeting kcna1

Info

Publication number
GB202204884D0
GB202204884D0 GBGB2204884.7A GB202204884A GB202204884D0 GB 202204884 D0 GB202204884 D0 GB 202204884D0 GB 202204884 A GB202204884 A GB 202204884A GB 202204884 D0 GB202204884 D0 GB 202204884D0
Authority
GB
United Kingdom
Prior art keywords
kcna1
sirna targeting
sirna
targeting
targeting kcna1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2204884.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fondo Ricerca Medica Srl
Original Assignee
Fondo Ricerca Medica Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fondo Ricerca Medica Srl filed Critical Fondo Ricerca Medica Srl
Priority to GBGB2204884.7A priority Critical patent/GB202204884D0/en
Publication of GB202204884D0 publication Critical patent/GB202204884D0/en
Priority to PCT/EP2023/058900 priority patent/WO2023194412A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/50—Physical structure
    • C12N2310/53—Physical structure partially self-complementary or closed
    • C12N2310/533—Physical structure partially self-complementary or closed having a mismatch or nick in at least one of the strands
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/30—Special therapeutic applications
    • C12N2320/34—Allele or polymorphism specific uses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB2204884.7A 2022-04-04 2022-04-04 Sirna targeting kcna1 Ceased GB202204884D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2204884.7A GB202204884D0 (en) 2022-04-04 2022-04-04 Sirna targeting kcna1
PCT/EP2023/058900 WO2023194412A1 (en) 2022-04-04 2023-04-04 Sirna targeting kcna1

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2204884.7A GB202204884D0 (en) 2022-04-04 2022-04-04 Sirna targeting kcna1

Publications (1)

Publication Number Publication Date
GB202204884D0 true GB202204884D0 (en) 2022-05-18

Family

ID=81581329

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2204884.7A Ceased GB202204884D0 (en) 2022-04-04 2022-04-04 Sirna targeting kcna1

Country Status (2)

Country Link
GB (1) GB202204884D0 (en)
WO (1) WO2023194412A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL155991A0 (en) 2000-12-01 2003-12-23 Max Planck Gesellschaft Rna interference mediating small rna molecules
EP3247363A4 (en) 2015-01-21 2018-10-03 Moderna Therapeutics, Inc. Lipid nanoparticle compositions
WO2016118725A1 (en) 2015-01-23 2016-07-28 Moderna Therapeutics, Inc. Lipid nanoparticle compositions

Also Published As

Publication number Publication date
WO2023194412A1 (en) 2023-10-12

Similar Documents

Publication Publication Date Title
EP3781196C0 (en) SEQUENCE-SPECIFIC IN VIVO CELL TARGETING
GB202002119D0 (en) Delivery optimisation
IL292065A (en) Variant igf2 constructs
IL275903A (en) Antisense oligonucleotides targeting alpha-synuclein and uses thereof
IL280581A (en) Variant rnai against alpha-synuclein
IL290499A (en) Extracellular vesicle-aso constructs targeting stat6
EP3740242B8 (en) Langerin+ cell targeting
GB201818110D0 (en) Monocytes for cancer targeting
IL286238A (en) Antibodies targeting c5ar
GB202014751D0 (en) Targeting vector
GB201905301D0 (en) Gene therapy
IL292718A (en) Cancer treatments targeting cancer stem cells
IL275902A (en) Antisense oligonucleotides targeting alpha-synuclein and uses thereof
GB202204884D0 (en) Sirna targeting kcna1
SG11202007450XA (en) Cancer therapeutic targeting using mutant p53-specific sirnas
GB201907802D0 (en) Cigarillo
PL4353666T3 (en) Stop point
NL2027653A (en) Targeting system with improved uptake
EP4043038A4 (en) Sirna expression vector
GB202108686D0 (en) Game delivery system
EP3934699A4 (en) NEUROPROTECTIVE GENE THERAPY TARGETING THE AKT PATHWAY
EP3996577C0 (en) Curved bougie guide
GB202011859D0 (en) Cytosolic delivery
GB201903873D0 (en) Enhanced transfection
GB202311983D0 (en) Stats sirna

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)